Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Vetter Expands Manufacturing Sites in USA and Germany
Vetter intends to relocate and expand its development services site from Skokie to Des Plaines, Illinois, bolstering its US presence The project also includes investments in commercial operations
SGS North America Expands Biologics Testing Capabilities in USA
SGS North America has expanded its capacity and capabilities to enhance biologics testing services in the USA The 60,000 squarefoot, stateoftheart facility in Lincolnshire
Bora Pharmaceuticals Expands Sterile Manufacturing Facility in Maryland, USA
Bora Pharmaceuticals plans for the expansion of sterile manufacturing facility in Maryland, USA to provide Sterile FillFinish Services The newly acquired 87,000
Novo Nordisk Invests US$4.1 billion to Expand Production Capacity in USA
Novo Nordisk plans to invest U$41 billion towards constructing a second fill and finish manufacturing facility in the USA The expansion project will increase production capacity significantly
LFB Biomanufacturing Expands its Biomedical Production Capacity in France, Europe
LFB Biomanufacturing is planning a capacity expansion of its industrial site in France, Europe The expansion will not only boost production capabilities
Thermo Fisher Scientific Invests US$58 million to Expand Research Laboratory in Wisconsin, USA
Thermo Fisher Scientific is investing $58 million to expand its GMP lab in Wisconsin, USA This new stateoftheart facility spans 72,500 square feet and includes a clinical research laboratory building
Sanofi Invests US$3.75 million (€3.5) to Open New Bioproduction Capacity in France
Sanofi is investing US$375 million 35 million to open new bioproduction capacity at its facilities in VitrysurSeine Val dae Marne, Loe Trait SeineMaritime, and Lyon Gerland Rhne in France
Kyowa Kirin Invests US$530 million for New Biologics Manufacturing Plant in USA
Kyowa Kirin invests US$530 million to construct a stateoftheart manufacturing facility in North Carolina, USA The 171,700squarefoot, tworeactor facility will accelerate the development
Aurigene Pharmaceutical Services Opens New Biologics Facility in India
Aurigene Pharmaceutical Services is set to open a new biologics facility in India, providing process development and clinicalscale manufacturing capabilities
Kymanox Expands Laboratory Service Offerings in USA
Kymanox is planning to expand its device design and testing facility, significantly enhancing its laboratory testing capabilities and increasing its CGxP footprint in the USA
